Rhumbline Advisers Tandem Diabetes Care Inc Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

A detailed history of Rhumbline Advisers transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Rhumbline Advisers holds 161,397 shares of TNDM stock, worth $6.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

161,397

Previous 172,081 6.21%

Holding current value

$6.52 Million

Previous $5.09 Million 12.28%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$22.09 - $35.41 $236,009 - $378,320	-10,684 Reduced 6.21%	161,397 $5.72 Million
Q4 2023 Feb 08, 2024	SELL	$14.28 - $31.03 $16,779 - $36,460	-1,175 Reduced 0.68%	172,081 $5.09 Million
Q3 2023 Nov 09, 2023	SELL	$19.33 - $36.22 $41,172 - $77,148	-2,130 Reduced 1.21%	173,256 $3.6 Million
Q2 2023 Aug 08, 2023	SELL	$24.18 - $42.46 $53,848 - $94,558	-2,227 Reduced 1.25%	175,386 $4.3 Million
Q1 2023 May 11, 2023	SELL	$35.86 - $46.5 $426,554 - $553,117	-11,895 Reduced 6.28%	177,613 $7.21 Million

Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $293,466 - $464,304	8,269 Added 4.56%	189,508 $8.52 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $68.97 $190,137 - $299,674	4,345 Added 2.46%	181,239 $8.67 Million
Q2 2022 Aug 11, 2022	BUY	$53.22 - $123.09 $735,713 - $1.7 Million	13,824 Added 8.48%	176,894 $10.5 Million
Q1 2022 May 12, 2022	BUY	$101.89 - $150.09 $11,513 - $16,960	113 Added 0.07%	163,070 $19 Million
Q4 2021 Feb 10, 2022	BUY	$118.18 - $153.21 $238,132 - $308,718	2,015 Added 1.25%	162,957 $24.5 Million
Q3 2021 Nov 12, 2021	BUY	$93.51 - $129.4 $9.51 Million - $13.2 Million	101,708 Added 171.71%	160,942 $19.2 Million
Q2 2021 Aug 05, 2021	SELL	$77.0 - $100.19 $299,068 - $389,137	-3,884 Reduced 6.15%	59,234 $5.77 Million
Q1 2021 May 06, 2021	SELL	$81.28 - $104.34 $228,965 - $293,925	-2,817 Reduced 4.27%	63,118 $5.57 Million
Q4 2020 Feb 10, 2021	SELL	$86.4 - $121.75 $55,900 - $78,772	-647 Reduced 0.97%	65,935 $6.31 Million
Q3 2020 Nov 12, 2020	SELL	$95.43 - $116.09 $239,720 - $291,618	-2,512 Reduced 3.64%	66,582 $7.56 Million
Q2 2020 Aug 13, 2020	SELL	$60.05 - $98.92 $714,835 - $1.18 Million	-11,904 Reduced 14.7%	69,094 $6.84 Million
Q1 2020 May 06, 2020	BUY	$47.37 - $90.04 $61,249 - $116,421	1,293 Added 1.62%	80,998 $5.21 Million
Q4 2019 Feb 05, 2020	BUY	$53.13 - $71.19 $166,881 - $223,607	3,141 Added 4.1%	79,705 $4.75 Million
Q3 2019 Oct 23, 2019	SELL	$57.11 - $73.3 $70,645 - $90,672	-1,237 Reduced 1.59%	76,564 $4.52 Million
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $523,315 - $689,610	9,618 Added 14.11%	77,801 $5.02 Million
Q1 2019 May 01, 2019	BUY	$32.25 - $73.56 $6,514 - $14,859	202 Added 0.3%	68,183 $4.33 Million
Q4 2018 Jan 31, 2019	BUY	$28.45 - $40.65 $632,301 - $903,446	22,225 Added 48.57%	67,981 $2.58 Million
Q3 2018 Nov 07, 2018	BUY	$21.39 - $51.17 $62,244 - $148,904	2,910 Added 6.79%	45,756 $1.96 Million
Q2 2018 Aug 06, 2018	BUY	$4.9 - $23.64 $209,945 - $1.01 Million	42,846 New	42,846 $943,000

Others Institutions Holding TNDM

# of Institutions

312

Shares Held

73.1M

Call Options Held

3.25M

Put Options Held

250K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.6B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Tandem Diabetes Care Inc Transaction History